The CREB-binding protein (CBP) is a large nuclear protein that regulates many signal transduction pathways and is involved in chromatin-mediated transcription. The translocation t(8;16)(p11;p13.3) consistently disrupts two genes: the CBP gene on chromosome band 16p13.3 and the MOZ gene on chromosome band 8p11. Although a fusion of these two genes as a result of the translocation is expected, attempts at detecting the fusion transcript by reverse transcriptase polymerase chain reaction (RT-PCR) have proven difficult; to date, only one inframe CBP/MOZ fusion transcript has been reported. We therefore sought other reliable means of detecting CBP rearrangements. We applied fluorescence in situ hybridization (FISH) and Southern blot analyses to a series of AML patients with a t(8;16) and detected DNA rearrangements of both the CBP and the MOZ loci in all cases tested. All six cases examined for CBP rearrangements have breakpoints within a 13 kb breakpoint cluster region at the 5′ end of the CBP gene. Additionally, we used a MOZ cDNA probe to construct a surrounding cosmid contig and detect DNA rearrangements in three t(8;16) cases, all of which display rearrangements within a 6 kb genomic fragment of the MOZ gene. We have thus developed a series of cosmid probes that consistently detect the disruption of the CBP gene in t(8;16) patients. These clones could potentially be used to screen other cancer-associated or congenital translocations involving chromosome band 16p13.3 as well.
Introduction
The CREB-binding protein (CBP) is a versatile nuclear organizer. In addition to participation in multiple cellular functions as a transcriptional co-activator (reviewed in Giles et al 1 ) , CBP has been recently identified as a histone acetyltransferase, suggesting that CBP coordinates chromatin-mediated and sitespecific transcription. 2, 3 In human disease, CBP is unique in that it is involved in both leukemogenesis and congenital disease. 4, 5 Two different somatic translocations involving the CBP gene are found in acute myelogenous leukemia (AML): the t(8;16)(p11;p13.3) and the t(11;16)(q23;p13.3). 4, [6] [7] [8] [9] [10] Moreover, constitutional translocations disrupting the CBP gene lead to the Rubinstein-Taybi syndrome (RTS), a complex developmental disorder that among other symptoms, leads to an increased incidence of neoplasia. 5 Of the two leukemia-associated translocations, the t(8;16) is the more common, with an occurrence of four per 1000 AML patients. 11 Since the first report of the translocation t(8;16) over a decade ago, 12 numerous studies (reviewed by Velloso et al 13 ) have ascertained that this translocation is a recurring cytogCorrespondence: MH Breuning, Department of Human Genetics, Sylvius Laboratories, Leiden University, Wassenaarseweg 72, 2333 AL, Leiden, The Netherlands; Fax: 31 71 527 6075 Received 9 July 1997; accepted 15 September 1997 enetic abnormality mainly associated with acute myelogenous leukemia (AML) M4/M5 French-American-British (FAB) subtypes.
14 All 42 previously reported patients 6, 13, 15 share a similar clinicopathologic profile. Most characteristic is the prominent erythrophagocytosis observed in 76% of t(8;16) cases, a phenomenon normally only observed in 1% of all AML cases. Patients frequently show evidence of extramedullary disease and prognosis is relatively poor. 13 We previously identified the CBP gene and that it is disrupted at its 5′ end by the t (8;16) , 5 between CBP amino acid residues 188-307. 4 A subsequent independent study confirmed our results and, in addition, showed that the MOZ gene is fused to the CBP gene as a result of the t(8;16). 6 The MOZ gene product is predicted to be 225 kDa, and it is considered to be a putative acetyltransferase based on its homology to yeast silencing genes. 16 Only one t(8;16) fusion event has been described at the sequence level, and in this patient both MOZ-CBP and the CBP-MOZ fusion transcripts were detected. 6 The breakpoints on both chromosomes of this patient occur in exons. Additional sequences of unknown origin are found in both transcripts: the incorporation of 2 bp maintains the open reading frame in the MOZ-CBP transcript, while the insertion of 39 bp in the CBP-MOZ transcript does not correct the frame-shift caused by the fusion, resulting in a premature stop codon in MOZ. Thus, the fusion protein responsible for leukemogenesis in the t(8;16) is most likely that with the orientation 5′-MOZ/CBP-3′, which leaves most of the interaction domains of both proteins intact. Alternatively, the reciprocal CBP-MOZ fusion is largely devoid of functional motifs, although this fusion would retain CBP's ability to act as a transcriptional coactivator in retinoid and other nuclear hormone receptor pathways. For unknown reasons, detection of the MOZ/CBP fusion transcripts is apparently difficult by reverse-transcriptase polymerase chain reaction (RT-PCR), and has only been successful in one case to date. Genomic rearrangements, however, have been more reliable to detect. 4, 6 Unlike the t(8;16)-associated AML, the t(11;16)-associated AML is never de novo, but arises as a consequence of prior anti-cancer treatment (therapy-related AML, t-AML). Preliminary results indicated that the MLL gene, on chromosome band 11q23, is one of the two partner genes in the t-AML with t(11;16). [17] [18] [19] The MLL gene (for mixed lineage leukemia), also known as ALL-1, HRX, or Htrx-1, has been shown to participate in many recurring rearrangements (reviewed in Ref. 20) . Recently, MLL/CBP fusions were detected by FISH in eight t-AML patients with a t(11;16). 8 MLL-CBP fusion transcripts have also been detected. 7, 9, 10 Analyses of the CBP breakpoints in MLL-CBP and CBP-MLL fusion transcripts in two t (11;16) patients revealed that three of the CBP breakpoints exactly correspond to the site of the previously reported t(8;16) breakpoint, while one additional breakpoint was localized further downstream, yet still within the 5′ half of CBP gene. Germline mutations inactivating one CBP allele cause the Rubinstein-Taybi syndrome (RTS). 5 RTS is a mental retardation syndrome characterized by broad big toes and thumbs as well as craniofacial abnormalities. 21, 22 RTS mutations include microdeletions of all or part of CBP, point mutations, inversions and translocations. It should be noted, however, that RTS translocations are thought to cause disease solely by disrupting one CBP allele, 23 as opposed to the translocations in leukemia which cause oncogenesis by the fusion of two genes. Although there is an increased neoplasia frequency in RTS patients, 24 the inactivation of one CBP allele does not lead to acute myelogenous leukemia.
The CBP gene has been cloned in cosmids, and the entire 7.3 kb cDNA sequence was recently reported. 1 We have developed an extensive series of primers in both the CBP and MOZ genes in order to detect MOZ/CBP fusion transcripts, but this approach has proven unfruitful despite accurate mapping of the genomic breakpoints. We therefore focused on developing alternative means of detecting t(8;16)-associated DNA rearrangements. Using two sets of cosmid probes in FISH, one representing the 5′ end of the CBP gene, and the other just 3′ of the breakpoint cluster region, we visualized CBP rearrangements in all six patients tested. To supplement these FISH results, Southern blots were performed. All patients tested exhibited rearranged bands with cosmid RT166. In short, we demonstrate a useful set of tools for the identification of CBP rearrangements in AML on the largest reported collection of AML patients with a translocation t(8;16).
Materials and methods

Patient samples
Fresh or cryopreserved viable cells from patients were obtained from the Department of Cytogenetics, Leiden University, Sylvius Laboratories, The Netherlands (cases A and B), the Division Autonome de Génétique Médicale, Lausanne, Switzerland (case C), the Medizinische Klinik und Poliklinik V, Universität Heidelberg, Germany (case D), the Centrum voor Menselijk Erfelijkheid, University of Leuven, Belgium (case E), the Department of Clinical Genetics, Erasmus University, Rotterdam, The Netherlands (case F), and the University of Nebraska Medical Center, Omaha, NE, USA (cases G and H). Cytogenetic data on cases A, D, and E were previously reported, 25, 26, 13 and a bone marrow transplantation was successful for patient A. 27 Patient F presented with AML after prior treatment for breast and brain tumors. Patient data are summarized in Table 1 .
Metaphase preparation
For patients A, B and D, a 24-h unstimulated bone marrow culture was synchronized by adding FUdR (to 100 nm total concentration) 17 h prior to harvest. BrdU (280 g/ml total concentration) was added for a further 5-6 h incubation. Colcemid was added 15 min before harvesting and the cultures were further processed according to standard techniques. 28 Bone marrow from patient C was handled as described elsewhere. 29 For the slides used for G-banding by Wright's stain and karyotype analysis in cases G and H, a direct culture as well as a 24-and 48-h culture period in unstimulated RPMI media supplement with GCT were used. The cells were exposed to a 37°C trypsin-hypotonic-colcemid (THC) solution and fixed with a 3:1 methanol:acetic acid mixture. Slides for metaphase analysis were prepared in ambient conditions with a high temperature (35°C) and low humidity (Ͻ15%) and aged briefly in a 100°C oven. The findings for all samples were described according to the international nomenclature (ISCN, 1995).
Fluorescence in situ hybridization (FISH)
One or two color FISH was performed as previously described. [30] [31] [32] FISH results were observed through a Leitz DM-RBE microscope (Leica, Rijswijk, The Netherlands) equipped for fluorescence microscopy and mounted with a Photometric Series 200, KAF1400 charged coupled device camera. Image acquisition and processing was performed on a Power Macintosh 7100, using the IP Lab Spectrum Multiprobe software (Photometrics, Munich, Germany). (a) The CBP genomic area on chromosome 16p13.3. The CBP gene, oriented from 5′-centromere to 3′-telomere, covers a 159 kb genomic area, and is covered by this cosmid contig. The 13 kb translocation breakpoint cluster region (BCR), representing 9/9 localized t(8;16) breakpoints and three t(11;16) breakpoints, is indicated by a black bar above the DNA line. An additional t(11;16) breakpoint is located further downstream and is indicated by a vertical arrow. A detailed restriction map of RT166 is given, with the translation start (ATG) positioned within a 1.3 kb EcoRI fragment. (b) Photograph of EcoRI-digested cosmids comprising CBP-contig. The 6.9 kb band shared by all cosmids represents the linearized vector, sCosI (arrowhead). Fragment size is determined by comparison with markers -bacteriophage digested with BstEII (M1), or HindIII (M2).
DNA extraction and Southern blot hybridization
Genomic DNA from t(8;16)-associated AML patients was isolated from fresh or cryopreserved bone marrow cells as previously reported. 33 All other genomic DNA was isolated directly from peripheral blood or EBV-transformed lymphoblastoid cell lines using the same protocol. YAC, cosmid, and plasmid DNA was extracted according to standard protocols. 34, 35 Restriction endonuclease digestions were carried out in One-Phor-All buffer PLUS (Pharmacia, Uppsala, Sweden). Digested DNA was run on a 0.8% agarose gel, and the separated fragments were transferred to Hybond N+ (Amersham) nylon membranes according to the manufacturer's recommendations. 10-20 ng of hybridization probes were 32 P-radiolabeled with random hexamers (Amersham), and repetitive elements were blocked by competition with 120 g of sonicated human placenta DNA for 2 h. 33 Membranes were hybridized overnight at 68°C, washed, and autoradiographed for 1-10 days.
Cosmid screening and contig assembly All chromosome 16 cosmids were identified from the Los Alamos National Laboratory flow-sorted chromosome 16 library kindly provided by NA Doggett and LL Deaven, 36, 37 with the exception of cosmid RT53. Although our laboratory generally uses in-house gridded filters of this library, 38 two cosmids in Figure 1 have a Los Alamos grid position identification: RT203 is 400H11, and RT166 is 420F6. Cosmid RT53 was subcloned from YAC 262A3 of the Washington University YAC library, 39 using established methods. 40 Chromosome 8 cosmids were identified by screening a flow-sorted chromosome 8 cosmid library 41 with a 0.45 kb MOZ cDNA fragment (bp 4312-4764) and a 0.7 kb MOZ genomic fragment generously provided by J Borrow. 6 The 0.7 kb MOZ genomic fragment was sequenced using fluorescein isothiocyanate (FITC)-labeled deoxyadenosine triphosphate (dATP) and running on the Automated Laser Fluorescent DNA sequencing apparatus according to the manufacturer's instructions (Autoread kit, fluorescent dATP labeling mix, ALF, Pharmacia). Contig assembly was as previously described. 
Results
Mapping the t(8;16) breakpoints in CBP by FISH
The CBP gene is dispersed over 159 kb and is covered by the cosmids RT100, RT102, RT191, RT203, RT166, and RT53 (Figures 1a and b) . Of these cosmids, RT53 is unique in that it is not derived from the flow-sorted chromosome 16 library, but is a subclone of a YAC (see Materials and methods). 5 Multiple internal deletions in RT53 preclude the construction of a precise restriction map of this cosmid. The translation start site and at least the first 798 bp of CBP coding sequences are represented by cosmid RT166. A 5 kb region between cosmids RT166 and RT203 has not been cloned because it is highly unstable. 1 This region is the site of or adjacent to the t(8;16) breakpoints we previously mapped.
Methanol-acetic acid fixed material for FISH studies was available for six of the eight t(8;16) cases collected (summarized in Table 1 ). Every cosmid shown in Figure 1 was tested in FISH experiments to determine its position relative to the t(8;16) breakpoints in the first four patients we collected (cases A-D). A pattern became apparent; in all four patients, the cosmid RT203 hybridized to the der(8) chromosome, placing it telomeric of the breakpoint. Signals from the cosmid RT166 were split between the der(8) and der(16) chromosomes in patients A, B and C, although the majority of the signal remained on the der(16), suggesting that these translocations break RT166 at the telomeric end (not shown). The results from patient D, which show that RT203 is translocated to the der(8) while cosmid RT166 remains wholly on the der (16) , are shown in Figure 2a . The conclusion we drew from these data is that the 16p breakpoints for all four of these patients was either in the telomeric end of RT166, or in the unstable 5 kb interval between RT203 and RT166. In all cases the expected signals from the unaffected chromosome 16 were observed.
Designing probe sets for two-color FISH detection of the t (8;16) All four previously tested t(8;16) patients exhibited CBP breakpoints in the telomeric end or just telomeric of RT166. We therefore strove to improve the detection by simultaneously hybridizing two probes on either side of the observed breakpoint region using two-color FISH. The probes chosen were pooled cosmids RT191 and RT203 (red, telomeric), and cosmids RT166 and RT53 (green, centromeric). The next two t(8;16) patients for whom we collected material for FISH (cases G and H) were examined using these two probes (Figure 2b) . Case G showed a small red/green colocalizing signal (seen as yellow), a loose green signal, and a large colocalizing red/green signal presumably from the unaffected chromosome 16, in 20/50 interphase nuclei scored (Figure 2b) . No metaphase chromosomes were found for this patient. Because the green signal was split but the majority of the green signal consistently appeared to remain on the der(16) chromosome, we judged this patient's breakpoint to be in the telomeric end of RT166. Both interphase as well as metaphase nuclei were available for analysis of case H. As in patient G, the interphase nuclei show three signals: a large colocalizing signal (yellow), a smaller colocalizing signal where the red signal is more prominent, and a loose green signal ( Figure  2b ). From this interphase signal pattern, it was thought that the CBP breakpoint also affected the telomeric end of RT166. The metaphase nuclei of this patient supported this conclusion. The der(8) chromosome shows a clear red signal and a small yellow signal, suggesting that a small part of the green signal was also translocated. The der (16) shows only green signals. The unaffected chromosome 16 shows a combination of red and green signals (yellow), as would be expected (Figure 2b ). The breakpoint in patient H therefore maps to the telomeric end of RT166.
Detecting CBP rearrangements by Southern blot analysis
Seeking to corroborate the FISH data by other means, we performed Southern blot analysis on two of the patients for whom FISH results had indicated that RT166 bridged their t(8;16) breakpoints (patients A and C). Patient DNA samples were digested with BamHI and StuI and after blotting, was hybridized with the entire cosmid RT166. In both cases, with both enzymes, one rearranged band was detected in addition to the wild-type signals (Figure 3a ). RT166 recognizes a rearranged 14 kb BamHI and a 7 kb StuI fragment in patient A, and a 5 kb BamHI and a 4 kb StuI fragment in patient C (Figure 3a) . Because the FISH studies indicated that patients A and C had breakpoints in telomeric RT166, we used the 8 kb BamHI telomeric end fragment of RT166 to rehybridize the same Southern blots. The same rearranged fragments in patients A and C were indeed detected (not shown). Southern analysis was not performed for patient D because FISH results had indicated that the breakpoint is between RT203 and RT166, where no appropriate hybridization probes are available. Therefore, all breakpoints are situated in a 13 kb interval encompassing the 8 kb telomeric end of RT166 and the adjacent 5 kb uncloned gap. No aberrant BamHI or StuI bands were detected by RT166 in a total of 34 control alleles checked (22 shown, Figure 3a) .
Detection of MOZ rearrangements
Because the patients we investigated all exhibited a t(8;16), a rearrangement of the MOZ gene on chromosome 8 is expected in addition to the observed CBP rearrangement. Southern blots with BamHI-digested patient DNA was therefore hybridized with a 0.45 kb fragment of the MOZ cDNA (bp 4312-4764) previously reported to recognize fusion fragments at the genomic level. 6 One aberrant band for each of the three tested patients (cases D, E and F) was accordingly observed, corresponding to 11, 8 and 10 kb, respectively ( Figure 3b ). All MOZ breakpoints reported to date are recognized by both or either the 0.7 kb or the 0.45 kb fragments described by Borrow et al. 6 Because the relationship of these two fragments was unclear, we screened a flow-sorted chromosome 8 cosmid library 41 with these two fragments and retrieved four cosmids, 62A3, 93H5, 159D4 and 163H9. Together, these cosmids comprise a 56 kb contig on chromosome band 8p11 (Figure 4 ). An EcoRI and BamHI restriction map was constructed, and the 0.45 kb MOZ cDNA and 0.7 kb genomic fragments were back-hybridized to this contig. These two fragments hybridize to the same 6 kb BamHI fragment, but to separate EcoRI fragments: the 0.45 kb cDNA probe to a 4.6 kb EcoRI fragment, and the genomic 0.7 kb fragment to the adjacent 5.1 kb EcoRI fragment. Thus, all known breakpoints in the MOZ gene cluster in this 6 kb BamHI fragment. We sequenced the 0.7 kb fragment from both sides of its cloning vector, pBluescript. Overlapping sequences indicated a complete 530 bp sequence (GenBank Accession NO. AF012283) containing no MOZ coding sequences. Database analyses revealed no significant homologies. Further analyses of the intron sequences within the 6 kb BamHI fragment may suggest a mechanism for the clustering of these t(8;16) breakpoints.
Discussion
We report here two methods of detecting the t(8;16), namely by FISH and by Southern blot analyses. We show that the breakpoints in CBP and in MOZ are clustered in 13 kb and 6 kb genomic regions, respectively. RT-PCR is currently the method of choice for reliable and sensitive molecular analyses of recurring chromosomal rearrangements in leukemia. Based on the localization of genomic breakpoints determined by FISH and by Southern blot analyses, we designed a RT-PCR strategy to detect fusion MOZ/CBP transcripts in five patients (A and C-F). Although both non-rearranged alleles were detected after a single round of RT-PCR in all five patients, fusion transcripts were not detected even after a third round of RT-PCR was performed using different sets of sequentially nested primers. Notably, only one of the five patients originally tested by Borrow et al 6 had detectable MOZ/CBP fusion transcripts, and no other groups have since reported MOZ/CBP fusion transcripts. Low expression or instability of the fusion transcript could account for this phenomenon. Then again, it is conceivable that one or more additional genes are involved in this translocation, as precedented by the t(3;21). This translocation results in the formation of both AML1-MDS1 and AML1-EAP fusion transcripts in the same patients. 42 The fact that CBP is prone to translocations, inversions, and deletions suggests the presence of elements leading to genomic instability. In addition to translocation t(8;16) breakpoints, we have also investigated the location of CBP translocation breakpoints in six RTS patients. Interestingly, five of the six RTS patients had breakpoints in the same 13 kb interval as nine t(8;16) and three t(11;16) AML patients. 5, 7, 9 Furthermore, we mapped the breakpoint of the remaining RTS patient to a 5.2 kb EcoRI fragment in cosmid RT102 (Figure 1b) , 5 which corresponds to the CBP coding sequence where the remaining t(11;16) breakpoint is localized. 9 Genomic analysis, and the complete intron-exon structure of CBP will determine if these two breakpoints precisely colocalize.
The cosmid probes for both CBP and MOZ are available for screening the possible involvement of these two genes in the t(8;16) as well as other malignancies and congenital disorders. For the t(8;16), detection may be improved by simultaneously hybridizing cosmids selected from both the CBP and MOZ loci in a two-color FISH experiment. Unfortunately, we were unable to perform this experiment due to lack of patient material. However, applications for these cosmid probes are not necessarily limited to the t(8;16). For example, a translocation t(9;16)(q22;p13) leading to basal cell carcinoma probably fuses the human version of the patched gene, a member of the key Hedgehog signaling pathway in development, to an unknown gene on 16p13.3. 43 A simple FISH experiment could implicate or exclude CBP as the target of this translocation. Likewise, the cosmids containing the MOZ breakpoint cluster region
Figure 4
The MOZ locus on chromosome 8p11. An EcoRI and BamHI restriction map of a cosmid contig surrounding the MOZ breakpoints in t(8;16) patients. The two probes that recognize MOZ rearrangements, a 0.45 kb MOZ cDNA fragment (hatched box) and a 0.7 kb genomic fragment (solid box), hybridize to the same BamHI fragment, but to adjacent EcoRI fragments. Hybridization with these two probes has identified all eight MOZ rearrangements tested, including three in this report, mapping these t(8;16) breakpoints all within the 6 kb BamHI fragment. described here could be used to resolve the molecular fusion in two AML patients described with a translocation t(8;22)(p11;q31). 44, 45 Both patients presented with the classical t(8;16) phenotype, and the case reports suggest that they are t(8;16) variants. Interestingly, CBP exhibits extensive homology to the E1A-associated protein p300, and the two proteins appear to be functionally homologous. 46 This molecular redundancy, coupled with the genomic location of p300 on chromosome band 22q13, 47 leads us to speculate that the t(8;22) is in fact a fusion involving p300 and MOZ.
